Small Increase Seen in Peer Support Services After Launch of 988

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Feb. 13, 2025 -- The launch of the 988 Suicide and Crisis Lifeline (988) did not coincide with growth in the availability of most crisis services, apart from a small increase in peer support services, according to a study published online Jan. 29 in JAMA Psychiatry.

Jonathan Cantor, Ph.D., from RAND in Santa Monica, California, and colleagues examined whether the launch of 988 was associated with the availability of crisis services in a cohort study characterizing trends in crisis services offered by U.S. mental health treatment facilities (MHTFs). Longitudinal data were obtained from the Mental Health and Addiction Treatment Tracking Repository.

The researchers found that across 15,623 MHTFs (184,769 observations: 79,268 before and 105,501 after the launch of 988), the largest changes were observed for availability of peer support services (increase from 39 to 42 percent) and emergency psychiatric walk-in services (decrease from 32 to 29 percent) from before to after the 988 launch. After the 988 launch, the odds of peer support availability increased 1.3 percent per month and odds of emergency psychiatric walk-in service availability decreased by 0.6 percent per month when controlling for MHTF characteristics (odds ratios, 1.013 and 0.994, respectively). At the national level, there was also a decrease seen in availability of other service types, with a decrease from 22 to 21 percent in mobile crisis response and from 69 to 68 percent in suicide prevention from before to after the 988 launch.

"Public health officials and policymakers may consider policies that boost the financing and availability of such services to increase the likelihood of success for 988," the authors write.

Abstract/Full Text (subscription or payment may be required)

Stay up to date on the latest in health — Click here to subscribe to our weekly newsletter!

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords